FDA Approves Immunotherapy for Certain Rectal Cancer Patients
The FDA approved an immunotherapy that may allow certain patients with rectal cancer to avoid chemotherapy, radiation and surgery.
Story updates
04:45:47 PM UTC
SquawkNews
By Mauro OrruGSK said the U.S. Food and Drug Administration approved Jemperli as an immunotherapy for adults with certain types of rectal cancer.The British pharmaceutical group said the FDA's accelerated approval was based on trial data showing a clinically significant proportion of participants w…